Involved field or Elective Nodal RT A Phase III trial in NSCLC
Local Control & Survival
Yuan et al Am.J.Clin.Oncol.
N patients
ENI
100
IFI
100
Local Control
1 Y
2 Y
5 Y
73 %
51 %
36 %
81 %
59 %
51 %
Failure
Elective nodal
Involved field
4 %
55 %
7 %
38 %